Last Days to Sign Up to SOLACI-SOCIME 2022 with 15% OFF

SOLACI-SOCIME 2022

LAST DAYS TO SIGN UP WITH 15% OFF

We are a little less than one month away from the most relevant meeting of interventional cardiology in Latin America.

This year we celebrate the long-awaited return to our face to face meetings. This is why we have prepared an innovative scientific program with challenging live and edited cases, prestigious international guests, outstanding symposia with the most relevant topics in the field, interesting academic debates and much more.

Do not miss this unique opportunity to make part of this event with 15% discount.

Register Now with 15% Discount

Discover the Preliminary Program

MORE INFORMATION ON THE CONGRESS

Call For Science – Last Days
Send your work before July 15 and introduce yourself to your colleagues around the world as an expert.
Send Your Work Now 

 

Live Cases
We will be broadcasting challenging live cases from 4 specialized centers in México and from Argentina.
Read Moreae

 

Sponsored Scientific Activities
Find out about innovative sessions in interventional cardiology sponsored by the industry.
Read More

 

Highlights | Why attend?
Find out why you cannot miss this event in the following link.
Read More 

 

Lodging Options
Book your stay in Mexico during SOLACI-SOCIME 2022 at the best hotels in the city at a special rate.
Read More

 

Register Now with 15% off


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....